Q87.87
Hao-Fountain Syndrome
Clinical Classification Guidelines
Use Additional Code
- code, if applicable, for associated conditions such as:
- autism spectrum disorder (F84.0)
- developmental speech disorder (F80.-)
- epilepsy, by specific type (G40.-)
- intellectual disabilities (F70-F79)
- pervasive developmental disorders (F84.-)
Inclusion Terms
- HAFOUS
Medical Intelligence & Overview
Hao-Fountain Syndrome is a rare genetic disorder classified under the ICD-10 code Q87.87. It is characterized by developmental delays and unique physical features caused by genetic variations. As a syndrome, it affects multiple parts of the body, leading to a combination of health and developmental challenges. Due to its rarity, Hao-Fountain Syndrome is not widely known, but understanding its key characteristics can help in early recognition and management.
Causes & Symptoms
Clinical Causes: Hao-Fountain Syndrome is caused by genetic mutations that are typically inherited or occur spontaneously. These mutations affect specific genes involved in growth and developmental processes. The exact cause involves alterations in the genetic material, leading to the disruption of normal biological functions. It is inherited in an autosomal dominant or recessive pattern, depending on the specific genetic changes involved. In some cases, genetic testing can identify the mutations responsible for the syndrome.
Key Symptoms: Intellectual disability and developmental delays Distinct physical features such as facial asymmetry, broad forehead, or abnormal facial features Speech and language delays Delayed motor skills development Behavioral challenges, including hyperactivity or social difficulties Possible congenital anomalies affecting various organs or tissues Short stature or growth abnormalities Seizures in some cases Feeding difficulties during infancy
Diagnostic & Treatment
Diagnosis Path: Diagnosing Hao-Fountain Syndrome involves a comprehensive clinical assessment, including detailed medical history and physical examination. Due to its genetic basis, confirmation is primarily achieved through genetic testing methods such as whole-exome sequencing or targeted gene panels that detect specific mutations. Additional assessments may include brain imaging, developmental evaluations, and symptomatic analyses. Early diagnosis can aid in tailored interventions and support planning.
Treatment Protocols: There is no specific cure for Hao-Fountain Syndrome. Management mainly focuses on addressing the unique symptoms and challenges of each individual. Treatment approaches may include:
Clinical Advice & FAQs
Billing Guidance
Is Q87.87 a billable ICD-10 code?
Yes, Q87.87 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Q87.87?
Clinical documentation must specify the nature of Hao-Fountain Syndrome and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
